Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Teva Pharmaceutical Inds Ltd (TEVA)

645 + Investors. Track Smart Money conviction in TEVA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +11
Streak
3Q ▲
Buyers last Q
54%

Smart Money Signals — TEVA

Based on 650 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added TEVA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
650 hedge funds hold TEVA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +18% more funds vs a year ago

fund count last 6Q
+100 new funds entered over the past year (+18% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 54% buying

338 buying287 selling
Last quarter: 338 funds bought or added vs 287 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-54 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 63 → 77 → 143 → 89. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

63% of holders stayed for 2+ years

■ 63% conviction (2yr+) ■ 16% medium ■ 21% new
408 out of 650 hedge funds have held TEVA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

72 → 63 → 77 → 143 → 89 new funds/Q
New funds entering each quarter: 63 → 77 → 143 → 89. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 68% of holders stayed 2+ years

■ 68% veterans ■ 11% 1-2yr ■ 21% new
Of 683 current holders: 462 (68%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 32% AUM from major funds

32% from top-100 AUM funds
62 of 650 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TEVA

In 2026 Q1, 338 hedge funds were net buyers of TEVA (89 opened a new position, 249 added to an existing one), while 287 reduced or exited (209 trimmed, 78 sold completely) — a 54% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 32% of total institutional value in TEVA is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +11 funds (more new holders than closures). Total institutional holders: 650.

Hedge Fund Ownership: TEVA

How many hedge funds hold TEVA — quarterly history vs. share price
Quarterly hedge fund ownership of TEVA vs. share price

Market Analysis: TEVA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TEVA

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Teva Pharmaceutical Inds Ltd (TEVA) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TEVA has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 73d ago
TEVA
+15.0%
XLV
+4.3%

TEVA outperformed XLV by +10.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 28d ago
TEVA
+1.0%
XLV
+5.3%

Since the filing became public, TEVA outperformed XLV by -4.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Strong Institutional Conviction

Multiple high-quality funds hold meaningful positions with strong conviction.

43 top-rated funds 21 high-conviction
Consensus
7.1
/ 10
breadth
×
Elite
6.0
/ 10
conviction
Hedge Fund Positioning: TEVA
645 + Investors

Track Smart Money conviction in TEVA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 645 639 0.94%
13F Shares 698M 737M -5.28%
Total Value $17.64B $19.13B -7.77%
New Positions 86 143 -57
Increased Positions 237 208 +29
Closed Positions 80 53 +27
Reduced Positions 201 190 +11
Total Calls 22 35 -37.14%
Total Puts 18 30 -40.0%
PUT/CALL Ratio 0.82 0.86 Neutral

Statistics: TEVA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

645 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TEVA. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TEVA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lingotto Investment Management LLP 16.52% 27,770,857 $836.5M
2 ION Fund Management Ltd 16.45% 3,859,443 $116.2M
3 Phoenix Financial Ltd. 12.21% 42,777,414 $1.29B
4 Migdal Insurance & Financial Holdings Ltd. 9.90% 37,902,212 $1.14B
5 Bridger Management, LLC 8.65% 367,600 $11.1M
6 Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) 7.16% 1,875,521 $56.5M
7 Altshuler Shaham Ltd 6.04% 11,463,621 $334.6M
8 Menora Mivtachim Holdings LTD. 5.65% 39,626,383 $1.19B
9 Sphera Funds Management LTD. 5.44% 1,136,975 $34.2M
10 Factorial Partners, LLC 5.07% 232,000 $7.0M
11 Glenview Capital Management, LLC 5.04% 6,660,220 $200.6M
12 Rubric Capital Management LP 4.87% 15,250,000 $459.3M
13 Tri Locum Partners LP 4.32% 1,021,008 $30.8M
14 Sound Shore Management Inc /Ct/ 3.92% 3,885,683 $117.0M
15 Continental Advisors LLC 3.72% 242,118 $7.3M
16 Highland Peak Capital, LLC 3.40% 421,153 $12.7M
17 Parrish Capital LLC 3.21% 113,737 $3.5M
18 DME Capital Management, LP 2.75% 2,910,729 $87.7M
19 Royal Palms Capital LLC 2.65% 88,790 $2.7M
20 Wcm Investment Management, LLC 2.64% 40,820,600 $1.16B
21 Mh & Associates Securities Management Corp /Adv 2.59% 98,487 $3.0M
22 DCF Advisers, LLC 2.41% 300,000 $9.0M
23 Yelin Lapidot Holdings Management Ltd. 2.23% 354,704 $10.7M
24 Todd Asset Management LLC 2.22% 3,771,672 $113.6M
25 Affinity Asset Advisors, LLC 2.18% 1,400,000 $42.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Teva Pharmaceutical Inds Ltd (TEVA)

What does the Smart Money Trend signal show for TEVA?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added TEVA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TEVA?

Slight buying edge — 54% buying: Last quarter: 338 funds bought or added vs 287 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TEVA holders?

Strong quality — 32% AUM from major funds: 62 of 650 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TEVA?

63% of holders stayed for 2+ years: 408 out of 650 hedge funds have held TEVA for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Teva Pharmaceutical Inds Ltd (TEVA) following the 2026 Q1 hedge fund 13F filings?

As of today, TEVA has moved +1.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.3% for the XLV sector ETF — an outperformance of -4.3%. Since the quarter end (March 31, 2026), TEVA has gained +15.0% vs +4.3% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →